Skip to main content

Table 1 Clinical characteristics of study participants with type 2 diabetes (n = 24)

From: Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring

Age, years

56.2 ± 8.9

Gender, male/female

14/10

Body mass index, kg/m2

26.7 ± 4.2

Duration of diabetes, years

5.3 ± 6.8

Systolic blood pressure, mmHg

122.6 ± 12.0

Diastolic blood pressure, mmHg

76.3 ± 11.0

Diabetes-related complications

 Neuropathy, n (%)

9 (37.0)

 Retinopathy, n (%)

7 (29.0)

 Nephropathy, n (%)

6 (25.0)

Fasting glucose, mmol/L

177.0 ± 56.0

IRI, μU/mL

9.3 ± 6.4

HbA1c, %

10.1 ± 2.4

Urinary CPR, μg/day

109.9 ± 61.2

AST, U/L

26.0 ± 12.3

ALT, U/L

28.1 ± 14.1

eGFR, mL/min/1.73 m2

86.1 ± 18.5

Uric acid, mg/dL

5.3 ± 1.3

  1. Data are mean ± SD or n (%)
  2. IRI immunoreactive insulin, HbA1c glycated hemoglobin, CPR C peptide immunoreactivity, eGFR estimated glomerular filtration rate